Eosinophilic esophagitis (EoE) is a potentially serious inflammatory condition that can result in ED visits for food impaction and can severely impact quality of life for patients. Nirmala Gonsalves, MD, of Northwestern’s Fineberg School of Medicine reviews the symptoms, diagnosis, and treatment of EoE, and provides tips for long-term control of this condition.
In this activity, Dr. Pandolfino will discuss frequently asked questions on esophageal dysphagia. He will review the finer points of diagnosing dysphagia and discuss different avenues and strategies for treating and managing dysphagia in your patients.
This activity offers expert insight into types of dietary fiber, their mechanisms of action in the body, beneficial impacts on cardiometabolic and digestive health, and how primary care providers can incorporate fiber counseling into their clinical practice.
This activity will use case-based scenarios to illustrate different patterns of liver test abnormalities. Dr. Han from the Dumont-UCLA Liver Transplant Center will discuss the difference between cholestatic versus hepatitis versus infiltrative liver diseases and their characteristic liver test patterns. Additionally, he will review the subsequent work-up of liver test abnormalities which are followed by supplemental serological testing, imaging, and in some cases, liver biopsy. He will also summarize the difference between true “liver function tests”, tests of cholestasis, tests of inflammation, and tests of infiltration.
The microbiome has been called the second human genome. It is shaped by how we were born, where we live and the foods and medicines we are given in childhood. In recent years, there has been an explosion in the number of scientific studies regarding the role of the gut microbiome in metabolic, allergic and autoimmune diseases. Therapeutic implications of altering the microbiome to alter disease states have taken shape and form an exciting new frontier of medicine.
In this Clinical Coffee Break, Dr. Sanjiv Chopra answers questions collected from his live talk on the burgeoning epidemic of nonalcoholic fatty liver disease, such as how to test for fibrosis, dietary influences on hepatic fibrosis, and others.
Dr. Leffler will address a few commonly asked questions about celiac disease. He will discuss some common issues like diagnostic tests, the right implementation of the gluten free diet and who can benefit from such a diet.
In this activity, Dr. Lee will discuss the advantages of early screening for gastric cancer. Using a case study as an example, she will review the pros and cons of available diagnostic tests. Finally, she will discuss premalignant condition such as gastric intestinal metaplasia and its association with gastric cancer.
The aim of this program is to review the role of “good bacteria” in digestive health as well as how probiotics are understood to work and the evidence for their use. This program will also address the limitations in the regulatory environment for probiotics.
In this activity, Dr. Damas will review the phenotypic manifestations and extra-intestinal manifestations of inflammatory bowel diseases, including Crohn’s and ulcerative colitis. She will explain what we currently know about disease pathogenesis, including the influence of genetics and the environment on the microbiome and finally, discuss some of the latest updates on treatment of IBD.
Nonalcoholic fatty liver (NAFL) is an emerging concern among a subset of the diabetic and obese population. Complications arise when the disease progresses to nonalcoholic steatohepatitis (NASH) and cirrhosis. It is important for the primary care physician to recognize the hallmarks of NAFLD and the progression to NASH. Here, Dr. Chopra discusses strategies for diagnosis, treatment and management of patients with this hepatic disorder.